{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T06:00:45Z","timestamp":1648965645802},"reference-count":0,"publisher":"Oceanside Publications Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2007,11,1]]},"DOI":"10.2500\/aap.2007.28.3061","type":"journal-article","created":{"date-parts":[[2008,1,5]],"date-time":"2008-01-05T21:32:52Z","timestamp":1199568772000},"page":"628-633","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacotherapy of asthma: What do the 2007 NAEPP guidelines say?"],"prefix":"10.2500","volume":"28","author":[{"given":"Michael","family":"Schatz","sequence":"first","affiliation":[{"name":"Department of Allergy, Kaiser-Permanente Medical Center, San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2007\/00000028\/00000006\/art00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T09:10:20Z","timestamp":1513069820000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2007.28.3061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11,1]]}},"alternative-id":["1088-5412(20071101)28:6L.628;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2007.28.3061","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11,1]]}}}